Brief: Xbrane, Partner Intas Agree On Revised Financing Arrangement
05/05/2026 06:10
May 5 (Reuters) - Xbrane Biopharma AB XBRANE.ST: XBRANE AND ITS PARTNER INTAS AGREE ON REVISED FINANCING ARRANGEMENT FOR XBRANE'S XDIVANE DEVELOPMENT ACTIVITIES Source text: ID:nMFN21kJmQ Further company coverage: XBRANE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Xbrane Biopharma AB
See all newsBrief: Xbrane Biopharma, JOINN Biologics US Partner To Develop Xdarzane
Brief: Xbrane Gets FDA BsUFA Review Date
Brief: Xbrane, Partner Intas Agree On Revised Financing Arrangement
Brief: Venture Valuation Provides External Valuation Of Xdivane Program
Brief: Xbrane Biopharma Submits BLA To FDA For Lucentis Biosimilar Candidate